| Literature DB >> 32104015 |
Zhe Liu1, Tiefeng Shen2, Dawei Wei1, Yong Yu1, Desheng Huang1,3, Peng Guan1.
Abstract
PURPOSE: To describe the incidence trend, demographic and clinical characteristics, treatment and prognosis, epidemiological history and risk factors of human brucellosis in Huludao, China. PATIENTS AND METHODS: A total of 1887 brucellosis patients were reported in Huludao, China from January, 2014 to December, 2018 and the case questionnaires from 1149 patients were collected from Huludao Municipal Center for Disease Control and Prevention. Demographic characteristics of the patients and the information relating to the patients' clinical manifestations, diagnosis, treatment and prognosis were collected and analyzed.Entities:
Keywords: clinical features; epidemiological characteristics; human brucellosis; treatment and prognosis
Year: 2020 PMID: 32104015 PMCID: PMC7023865 DOI: 10.2147/IDR.S236326
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Figure 1Annual reported cases and the incidence of human brucellosis in Huludao, China, 2014–2018.
Figure 2The number of monthly reported human brucellosis in Huludao, China, 2014–2018.
Demographic Characteristics of Human Brucellosis in Huludao, 2014–2018
| Variable | Number (Total, N=1149) | Proportion (%) |
|---|---|---|
| 0–20 | 30 | 2.6 |
| 21–40 | 215 | 18.7 |
| 41–60 | 686 | 59.7 |
| >60 | 218 | 19.0 |
| Male | 870 | 75.7 |
| Female | 279 | 24.3 |
| Han Nationality | 551 | 48.0 |
| Ethnic minority | 221 | 19.2 |
| No response | 377 | 32.8 |
| Farmer/Herdsmen | 722 | 62.8 |
| Unemployment/Retirees | 24 | 2.1 |
| Worker/Laborer | 21 | 1.9 |
| Student/Teacher | 12 | 1.0 |
| Cadres | 3 | 0.3 |
| Public service staff | 2 | 0.2 |
| Other | 13 | 1.1 |
| No response | 352 | 30.6 |
Figure 3The regional distribution of human brucellosis in Huludao, China, 2014–2018.
Clinical Manifestations of Human Brucellosis in Huludao, 2014–2018
| Clinical Manifestations | Total (N) | Number of Positive Patients (n) | Proportion (%) |
|---|---|---|---|
| Fatigue | 600 | 525 | 87.5 |
| Hyperhidrosis | 1057 | 915 | 86.6 |
| Fever | 1074 | 906 | 84.4 |
| Arthralgia/Myalgia | 1067 | 899 | 84.3 |
| Enlarged spleen | 995 | 158 | 15.9 |
| Hepatauxe | 992 | 79 | 8.0 |
| Lymphadenectasis | 984 | 33 | 3.4 |
| Testicle swelling | 962 | 16 | 1.7 |
Notes: N: the total number of the patients who recorded whether they had the symptoms; n: the number of patients who had the corresponding symptoms.
Clinical Manifestations of Human Brucellosis in Different Age Groups, Gender, Ethnicity and District in Huludao, China, 2014–2018
| Variables (%, n/N) | Clinical Manifestations | |||||||
|---|---|---|---|---|---|---|---|---|
| Fever (%, N=1074) | Hyperhidrosis (N=1057) | Arthralgia/Myalgia (N=1067) | Body Temperature (°C) (N=820) | Enlarged Spleen (N=995) | Hepatauxe (N=992) | Lymphaden-Ectasis (N=984) | Testicle Swelling (N=962) | |
| 0–20 (N=30) | 92.9 (26/28) | 85.7 (24/28) | 57.1 (16/28) | 38.64±0.65 | 18.5 (5/27) | 0.0 (0/27) | 7.4 (2/27) | 3.7 (1/27) |
| 21–40 (N=215) | 85.9 (171/199) | 81.3 (157/193) | 77.3 (150/194) | 38.82±0.45 | 11.5 (21/182) | 8.2 (15/183) | 2.8 (5/181) | 1.1 (2/177) |
| 41–60 (N=686) | 83.8 (537/642) | 87.8 (556/634) | 85.8 (548/640) | 38.74±0.69 | 15.3 (92/602) | 7.7 (46/599) | 3.7 (22/595) | 1.9 (11/581) |
| >60 (N=218) | 83.9 (172/205) | 88.1 (178/202) | 90.2 (185/205) | 38.75±0.94 | 21.7 (40/184) | 9.8 (18/183) | 2.2 (4/181) | 1.1 (2/177) |
| 0.535 | 0.130 | 0.000 | 0.504 | 0.055 | 0.349 | 0.473 | 0.684 | |
| Male (N=870) | 84.2 (687/816) | 86.8 (701/808) | 85.1 (692/813) | 38.78±0.75 | 17.6 (134/760) | 8.4 (64/759) | 3.7 (28/751) | 2.2 (16/731) |
| Female (N=279) | 84.9 (219/258) | 85.9 (214/249) | 81.5 (207/254) | 38.68±0.55 | 10.2 (24/235) | 6.4 (15/233) | 2.1 (5/233) | 0.0 (0/231) |
| 0.790 | 0.742 | 0.168 | 0.088 | 0.007 | 0.325 | 0.241 | 0.093 | |
| Han nationality (N=551) | 85.4 (444/520) | 87.5 (449/513) | 86.8 (449/517) | 38.60±0.96 | 10.2 (47/463) | 10.9 (51/446) | 5.4 (25/459) | 0.9 (4/451) |
| Ethnic minority (N=221) | 90.0 (197/219) | 91.0 (191/210) | 86.5 (186/215) | 38.84±0.37 | 27.8 (55/198) | 8.8 (17/193) | 2.6 (5/192) | 3.8 (7/186) |
| No response (N=377) | 79.1 (265/335) | 82.3 (275/334) | 78.8 (264/335) | 38.90±0.35 | 16.8 (56/334) | 3.3 (11/333) | 0.9 (3/333) | 1.7 (5/325) |
| 0.002 | 0.011 | 0.004 | 0.000 | 0.000 | 0.000 | 0.002 | 0.035 | |
| 0.094 | 0.189 | 0.903 | 0.000 | 0.000 | 0.412 | 0.115 | 0.018 | |
| 0.001 | 0.006 | 0.001 | 0.000 | 0.586 | 0.000 | 0.002 | 0.829 | |
| Jianchang (N=88) | 97.7 (86/88) | 89.7 (78/87) | 87.7 (71/81) | 38.39±0.66 | 3.1 (2/64) | 3.1 (2/64) | 0.0 (0/64) | 0.0 (0/64)) |
| Lianshan (N=104) | 68.5 (63/92) | 83.3 (75/90) | 78.3 (72/92) | 38.60±0.69 | 18.7 (17/91) | 27.5 (25/91) | 16.5 (15/91) | 3.5 (3/85) |
| Longgang (N=28) | 96.4 (27/28) | 67.9 (19/28) | 75.0 (21/28) | 38.35±0.77 | 3.6 (1/28) | 7.1 (2/28) | 10.7 (3/28) | 0.0 (0/28) |
| Nanpiao (N=149) | 78.0 (110/141) | 84.4 (119/141) | 90.1 (121/141) | 38.49±1.52 | 0.0 (0/141) | 0.0 (0/141) | 1.4 (2/141) | 0.7 (1/139) |
| Suizhong (N=106) | 89.3 (67/75) | 82.7 (62/75) | 74.7 (56/75) | 38.53±0.52 | 8.0 (6/75) | 2.7 (2/75) | 1.3 (1/75) | 0.0 (0/74) |
| Xingcheng (N=343) | 91.7 (297/324) | 95.2 (296/311) | 91.0 (295/324) | 38.86±0.37 | 27.8 (75/270) | 13.1 (35/267) | 3.1 (8/259) | 2.8 (7/253) |
| No response (N=331) | 78.5 (256/326) | 81.8 (266/325) | 78.8 (257/326) | 38.91±0.33 | 17.5 (57/326) | 4.0 (13/326) | 1.2 (4/326) | 1.6 (5/319) |
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.426 | |
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.321 | |
| 0.001 | 0.003 | 0.001 | 0.000 | 0.333 | 0.001 | 0.009 | 0.870 | |
Notes: P1-value means the differences among two ethnic groups and the non-respondents or six districts and the non-respondents; P-value means the differences between two ethnic groups or six districts excluding the non-respondents; P-value means the differences between the responded group and the non-respondents.
Clinical Diagnosis of Human Brucellosis in Different Age Groups, Gender, Ethnicity and District in Huludao, China, 2016–2018
| Variable (%, n/N) | Diagnosis | OR | |||
|---|---|---|---|---|---|
| Acute (n=202) | Sub-Acute (n=51) | Chronic (n=36) | |||
| 0–20 (N=5) | 4 (80.0) | 0 | 1 (20.0) | 0.80 | 0.021 |
| 21–40 (N=58) | 36 (62.1) | 14 (24.1) | 8 (13.8) | ||
| 41–60 (N=167) | 117 (70.1) | 31 (18.6) | 19 (11.4) | ||
| >60 (N=59) | 45 (76.3) | 6 (10.2) | 8 (13.6) | ||
| Female (N=80) | 48 (60.0) | 20 (25.0) | 12 (15.0) | 1.00 | |
| Male (N=209) | 154 (73.7) | 31 (14.8) | 24 (11.5) | 0.57 | 0.037 |
| Han Nationality (N=207) | 134 (64.7) | 46 (22.2) | 27 (13.0) | 1.00 | |
| Ethnic minority (N=73) | 61 (83.6) | 4 (5.5) | 8 (11.0) | 0.40 | 0.006 |
| No response (N=9) | 7 (77.8) | 1 (11.1) | 1 (11.1) | ||
| Jianchang (N=60) | 13 (21.7) | 42 (70.0) | 5 (8.3) | 1.00 | |
| Lianshan (N=34) | 19 (55.9) | 3 (8.8) | 12 (35.3) | 0.68 | 0.344 |
| Longgang (N=16) | 3 (18.8) | 1 (6.2) | 12 (75.0) | 8.03 | 0.001 |
| Nanpiao (N=3) | 0 | 1 (33.3) | 2 (66.7) | 7.24 | 0.117 |
| Suizhong (N=60) | 53 (88.3) | 3 (5.0) | 4 (6.6) | 0.07 | <0.001 |
| Xingcheng (N=113) | 112 (99.1) | 1 (0.9) | 0 | 0.01 | <0.001 |
| No response (N=3) | 2 (66.7) | 0 | 1 (33.3) | ||
Laboratory Findings of Human Brucellosis in Different Years in Huludao, China (2014–2018)
| Positive Serum Agglutination Test (SAT) | 2014 (n) | 2015 (n) | 2016 (n, %) | 2017 (n, %) | 2018 (n, %) |
|---|---|---|---|---|---|
| SAT ≥1:100 | 195† | 330† | 2 (2.7) | 5 (6.0) | 5 (5.9) |
| SAT ≥1:400 | 8 (10.7) | 20 (23.8) | 21 (24.7) | ||
| SAT ≥1:800 | 18 (24.0) | 28 (33.3) | 35 (41.2) | ||
| SAT ≥1:1600 | 47 (62.7) | 31 (36.9) | 24 (28.2) | ||
| Total (N=769) | 195 (25.4) | 330 (42.9) | 75 (9.8) | 84 (10.9) | 85 (11.1) |
Note: †there was no specific indication of the antibody titre in the corresponding case questionnaire.
Abbreviation: SAT, serum agglugitation test.
Figure 4The drug combination used for 89 human brucellosis patients in Huludao, China, 2014–2018.
Treatment and Prognosis of Human Brucellosis in Huludao, China, 2014–2018
| Prognosis | ||||
|---|---|---|---|---|
| Recovery (%) | Improved (%) | Not improved (%) | ||
| With treatment information (n=594) | Antibiotic therapy (n=592) | 89 (15.0) | 499 (84.3) | 4 (0.7) |
| Traditional Chinese Medicinal therapy (n=2) | 0 | 2 (100.0) | 0 | |
| Without treatment information (n=174) | 51 (29.3) | 117 (67.2) | 6 (3.5) | |
| Total (N=768) | 140 (18.2) | 618 (80.5) | 10 (1.3) | |
Exposure Distribution of Livestock Species and Routes of Contacting with Livestock for Human Brucellosis in Huludao, China, 2014–2018
| Routes of Contacting with Livestock (N=1023) | Species of Livestock | |||||
|---|---|---|---|---|---|---|
| Sheep/Goat Only (%) | Cattle/Cow Only (%) | Sheep & Cattle (%) | Pig (%) | Dog (%) | ||
| Feeding and grazing (n=816) | 801 (98.2) | 8 (1.0) | 5 (0.6) | 1 (0.1) | 1 (0.1) | 0.007 |
| Slaughter/animal product processing (n=18) | 15 (83.3) | 1 (5.6) | 0 | 2 (11.1) | 0 | |
| Animal trafficking/animal trading (n=8) | 8 (100.0) | 0 | 0 | 0 | 0 | |
| Veterinary/breeder (n=5) | 4 (80.0) | 1 (20.0) | 0 | 0 | 0 | |
| Living around livestock farmer (n=86) | 83 (96.5) | 2 (2.3) | 1 (1.2) | 0 | 0 | |
| Other (n=90) | 90 (100) | 0 | 0 | 0 | 0 | |
| Total (n, %) | 1001(97.8) | 12 (1.2) | 6 (0.6) | 3 (0.3) | 1 (0.1) | |
Distribution of Personal Protection Options and High-Risk Behavior of Human Brucellosis Cases in Huludao, China, 2014–2018
| Investigated Items | Number of Respondents | Number of People Who Answered “Yes” (%) | Year | ||||
|---|---|---|---|---|---|---|---|
| 2014 | 2015 | 2016 | 2017 | 2018 | |||
| Adoption of protective measures | |||||||
| Wearing masks | 393 | 66 (16.8) | - | - | 13 | 7 | 46 |
| Wearing gloves | 369 | 44 (11.9) | - | - | 15 | 6 | 23 |
| Wearing protective clothing | 951 | 21 (2.2) | 1 | 15 | 1 | 0 | 4 |
| Using disinfectant | 851 | 18 (2.1) | 2 | 5 | 0 | 4 | 7 |
| High-risk behaviors | |||||||
| Drinking water from the same well with livestock | 477 | 413 (86.6) | 126 | 287 | - | - | - |
| Keeping young lambs indoors | 471 | 22 (4.7) | 11 | 11 | - | - | - |
| Eating undercooked meat or consuming unpasteurized/raw dairy products | 394 | 10 (2.5) | - | - | 4 | 2 | 4 |
Note: “-” indicates the item was not included in the case questionnaire in the corresponding year.